Almaty 1 Free Papers
Date
Wed, Apr 11, 2018
Time
14:15 - 15:45
Location
Almaty 1
Moderators
  • A. Gobbi (Milano, Italy)
  • G. Knutsen (Tromsoe, Norway)
Podium Presentation Clinical Outcome

21.2.1 - Comparison of Microfracture Alone and Microfracture with BMAC Augmentation for Medial Unicompartmenal Osteoarthritis (ID 10173)

Presentation Number
21.2.1
Topic
Clinical Outcome
Lecture Time
14:15 - 14:24
Corresponding Author
  • E. Song (Gwangju, Korea, Republic of)
Authors
  • J. Seon (Gwangju, Korea, Republic of)
  • E. Song (Gwangju, Korea, Republic of)
Disclosure
No Significant Commercial Relationships
Podium Presentation Clinical Outcome

21.2.2 - Functional Results of 5 Years after Aulogous Matrix-Induced Chondrogenesis (AMIC) for Talar Osteochondral Lesions (ID 10109)

Presentation Number
21.2.2
Topic
Clinical Outcome
Lecture Time
14:24 - 14:33
Corresponding Author
  • O. Gottschalk (Munich, Germany)
Authors
  • O. Gottschalk (Munich, Germany)
  • S. Altenberger
  • M. Walther (München, Germany)
Disclosure
O. Gottschalk, Company Geistlich, Grant Research Support M. Walther, Company Geistlich, Consultant
Podium Presentation Cartilage /Cell Transplantation

21.2.3 - Comparison Between Patellofemoral Joint and Femoral Condyles Cartilage Lesions after Mesenchymal Stem Cells Implantation (ID 10214)

Presentation Number
21.2.3
Topic
Cartilage /Cell Transplantation
Lecture Time
14:33 - 14:42
Corresponding Author
  • M. Iosifidis (Thessaloniki, Greece)
Authors
  • M. Iosifidis (Thessaloniki, Greece)
  • T. Kyriakidis
  • E. Michalopoulos
  • A. Mpitoudi
  • M. Fylaktou
  • A. Stavropoulos
Disclosure
No Significant Commercial Relationships
Podium Presentation Cartilage /Cell Transplantation

21.2.4 - Improve Autologous Chondrocyte Implantation Using Blood Clot As A Bioscaffold For Cartilage Regeneration Of The Knee (ID 9872)

Presentation Number
21.2.4
Topic
Cartilage /Cell Transplantation
Lecture Time
14:42 - 14:51
Corresponding Author
  • Y. Sun (Nanjig, China)
Authors
  • C. Jin (NanJing, China)
  • Y. Sun (Nanjig, China)
  • C. Huang
  • S. Ma
  • K. Song
  • X. Li
  • B. Min (Suwon, Korea, Republic of)
Disclosure
No Significant Commercial Relationships
Podium Presentation Cartilage /Cell Transplantation

21.2.5 - Assessment Of Cartilage Growth After Biopsy Of Osteochondral Loose Bodies For Use In Autologous Chondrocyte Implantation (ID 9524)

Presentation Number
21.2.5
Topic
Cartilage /Cell Transplantation
Lecture Time
14:51 - 15:00
Corresponding Author
  • B. Haus (, United States of America)
Authors
  • S. Robinson (Oakland, United States of America)
  • J. Kramer
  • T. Shelton
  • J. Merriman
  • B. Haus (, United States of America)
Disclosure
No Significant Commercial Relationships
Podium Presentation Subchondral Bone

21.2.6 - Long Term Results Using an Osteochondral Biomimetic Scaffold in Knee Isolated Osteochondral Defects (ID 9911)

Presentation Number
21.2.6
Topic
Subchondral Bone
Lecture Time
15:00 - 15:09
Corresponding Author
  • M. Berruto (Milano, Italy)
Authors
  • M. Berruto (Milano, Italy)
  • P. Ferrua
  • D. Tradati (MIlano, Italy)
  • A. Maione
  • S. Pasqualotto
  • M. Ricci
  • E. Usellini
Disclosure
No Significant Commercial Relationships
Podium Presentation Clinical Outcome

21.2.7 - Matrix-Induced Autologous Chondrocyte Implantation Addressing Focal Chondral Defect In Knee A Clinical Follow Up (ID 9801)

Presentation Number
21.2.7
Topic
Clinical Outcome
Lecture Time
15:09 - 15:18
Corresponding Author
  • J. Fang (, United States of America)
Authors
  • X. Dai (Hangzhou, China)
  • J. Fang (, United States of America)
  • J. Luo
  • X. Yu (Hangzhou, China)
  • W. Shen
  • M. Zhang
  • S. Zhu
Disclosure
No Significant Commercial Relationships
Podium Presentation Cartilage /Cell Transplantation

21.2.8 - Cryopreserved Osteochondral Allograft, ProChondrix® CR Maintains Metabolically Active And Viable Cells (ID 9711)

Presentation Number
21.2.8
Topic
Cartilage /Cell Transplantation
Lecture Time
15:18 - 15:27
Corresponding Author
  • C. Barrett (Denver, United States of America)
Authors
  • C. Barrett (Denver, United States of America)
  • A. Nelson (, United States of America)
  • R. Sakthivel
Disclosure
C. Barrett, AlloSource, Employee A-L. Nelson, AlloSource, Employee R. Sakthivel, AlloSource, Employee
Podium Presentation Chondrocytes

21.2.9 - High-Density Autologous Chondrocyte Implantation (HD-ACI) for the Ankle Treatment: 2-Years Follow-Up (ID 10062)

Presentation Number
21.2.9
Topic
Chondrocytes
Lecture Time
15:27 - 15:36
Corresponding Author
  • E. Rodriguez Iñigo (Madrid, Spain)
Authors
  • P. Guillen (Madrid, Spain)
  • I. Guillen-Vicente (Madrid, Spain)
  • E. Rodriguez Iñigo (Madrid, Spain)
  • R. Navarro
  • T. Fernandez
  • M. Guillen-Vicente (Madrid, Spain)
  • R. Caballero
  • M. Casqueiro
  • A. Platero
  • P. Martinez
  • J. Izpisua
  • S. Abelow (South Lake Tahoe, United States of America)
  • J. Lopez-Alcorocho (Madrid, Spain)
Disclosure
No Significant Commercial Relationships
Podium Presentation Cartilage /Cell Transplantation

21.2.10 - Arthroscopic Technique of Autologous Chondrocyte Implantation vs Microfracture to treat cartilage lesions in patella (ID 10047)

Presentation Number
21.2.10
Topic
Cartilage /Cell Transplantation
Lecture Time
15:36 - 15:45
Corresponding Author
  • A. Olivos Meza (Mexico city, Mexico)
Authors
  • A. Olivos Meza (Mexico city, Mexico)
  • F. Perez Jimenez
  • E. Villalobos Jr (Mexico City, Mexico)
  • S. Cortes González
  • A. Almazan (Mexico city, Mexico)
  • F. Cruz Lopez
  • M. Saldaña Garcia
  • C. Nieto Gomez
  • C. Ibarra (Mexico city, Mexico)
Disclosure
No Significant Commercial Relationships